[MDGL] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -8.78%
YoY- -151.75%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -81,197 -63,100 -57,963 -21,429 -8,512 -8,363 -14,049 33.94%
Tax 1,502 0 0 0 0 100 -11,991 -
NP -82,699 -63,100 -57,963 -21,429 -8,512 -8,363 -14,049 34.35%
Tax Rate - - - - - - - -
Total Cost 82,699 63,100 57,963 21,429 8,512 8,363 14,049 34.35%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -4.84 -3.79 -3.75 -1.39 -0.56 -0.68 -1.59 20.37%
EPS Diluted -4.84 -3.79 -3.75 -1.39 -0.56 -0.68 -1.59 20.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.